Climb Bio, Inc. Common Stock

CLYM

Climb Bio, Inc. (CLYM) is a biotechnology company focused on developing innovative therapies targeting neurodegenerative diseases. The company leverages its proprietary platforms to discover and advance drug candidates aimed at addressing unmet medical needs in neurosciences.

$5.03 +0.52 (11.35%)
🚫 Climb Bio, Inc. Common Stock does not pay dividends

Company News

Climb Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc. • Carlo Tanzi, Ph.D. • November 25, 2025

Climb Bio granted a non-statutory stock option to a new employee for 120,000 shares at $1.76 per share, vesting over four years with standard stock option terms.

Related Companies

Euro Tech Holdings Co Ltd. New
Euro Tech Holdings Co Ltd. New
CLWT
Clorox Company
Clorox Company
CLX
Comerica Incorporated
Comerica Incorporated
CMA
Canadian Imperial Bank of Commerce
Canadian Imperial Bank of Commerce
CM